Home > Insider Trading > Filing (0001567619-19-012237)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1676725	Ideaya Biosciences Inc.	IDYA	()	E9

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1619859	L.p. X Canaan	C/O Canaan Partners 285 Riverside Avenue, Suite 250 Westport CT 06880		No	No	Yes	No
1673228	Canaan Partners X Llc	C/O Canaan Partners 285 Riverside Avenue, Suite 250 Westport CT 06880		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-05-28	1,658,164	$0.00	1,658,164	No	4	C	Direct
Common Stock	Acquisiton	2019-05-28	602,549	$0.00	2,260,713	No	4	C	Direct
Common Stock	Acquisiton	2019-05-28	400,000	$10.00	2,660,713	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2019-05-28	1,658,164	$0.00	1,658,164	$0.00
Common Stock	Series B Preferred Stock	Disposition	2019-05-28	602,549	$0.00	602,549	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
0			No	4	C	Direct

Footnotes

Reflects a 1-for-10.2564 reverse stock split of the Issuer's outstanding securities effected prior to the effectiveness of the Issuer's S-1 Registration Statement.
Each share of Series A Preferred Stock was automatically converted on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering.
The reported securities are held directly by Canaan X L.P. (the "Canaan Fund"). The sole general partner of the Canaan Fund is Canaan Partners X LLC ("Canaan X"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Investment and voting decisions with respect to the shares held by the Canaan Fund are made by the managers of Canaan X, collectively. Canaan X disclaims Section 16 beneficial ownership of the securities held by the Canaan Fund, except to the extent of its pecuniary interest therein, if any.
Each share of Series B Preferred Stock was automatically converted on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering.